In Costly Cancer Drug, Hope and a Dilemma: Some Pay Up to $100,000 a Year for Avastin's Arguable Benefits

Creator
Kolata, Gina
Pollack, Andrew
Bibliographic Citation
New York Times 2008 July 6; p. A1, A16, A17
Permanent Link
Find in a Library
http://hdl.handle.net/10822/956184
Date
2008-07-06
Subject
Collections
Metadata
Show full item record
Georgetown University Seal
©2009—2018 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885